Human erythrocyte band 4.2 is a major membrane-associated protein with an important, but still undefined, role in erythrocyte survival. We previously sequenced the complete cDNA for band 4.2 and showed that the protein has a strong sequence identity with the transglutaminase family of proteins but lacks transglutaminase activity. Here we have analyzed the genomic organization of band 4.2. The band 4.2 gene is =20 kilobases, consisting of 13 exons and 12 introns. Reticulocytes contain two different sized messages for band 4.2, and our results show that the major, smaller, message is produced by alternative splicing within band 4.2 exon I. The upstream region of the gene has several prospective promoter elements arranged in a pattern similar to that of two other erythroid genes, (3-globin and porphobilinogen deamiase.
Alignment of the band 4.2 amino acid sequence with that of the a subunit of human coagulation factor XI and division of the sequences into exons reveal a remarkable correspondence, and in most cases identity, in the sizes of the paired exons. Moreover, each corresponding intron of the two genes is of an identical splice junction class. These and other similarities suggest that the gene for band 4.2 is closely related to and possibly derived from that for the a subunit of factor XIII and that the proteins may share common structural and functional properties.
Human erythrocyte band 4.2 is a major membrane-associated protein of 72 kDa and is present at ==200,000 copies per cell (1, 2) . Band 4.2 is clearly important for normal erythrocyte function since patients whose erythrocytes are deficient in or lack band 4.2 are anemic due to accelerated erythrocyte destruction and have abnormally shaped, possibly fragile, erythrocytes (3) (4) (5) . In spite of this, however, the exact function of band 4.2 in the erythrocyte remains unclear. We have recently cloned and sequenced the full-length cDNA for band 4.2 (ref. 6 ; see also ref. 7) . We found that the amino acid sequence of human erythrocyte band 4.2 has homology with two transglutaminases, guinea pig liver transglutaminase, and the a subunit of human coagulation factor XIII. The region of most striking identity includes a 49-amino acid domain of band 4.2, which is 69% and 51% identical to the corresponding domains of guinea pig liver transglutaminase and of the a subunit of factor XIII, respectively, and which spans the regions containing the active sites (8, 9) of both enzymes. However, band 4.2 has no demonstrable crosslinking activity when tested in vitro (6) .
In principle, the sequence similarities of band 4.2 with the transglutaminases could have arisen as the result of convergent evolution, in which each class of proteins evolved common, but as yet undetermined, functions independently, or, more likely, by divergent evolution, in which case the proteins would be expected to have arisen from a common ancestral gene. This question can be resolved by comparing the organization of the gene for band 4.2 with those of the transglutaminases, since a similar gene organization and sequence would imply a common gene ancestor. In this paper, we present the complete gene organization of human erythrocyte band 4.2 § and compare it with that of the a subunit of human factor XIII, the only transglutaminase whose gene structure has been determined (10).
METHODS
Library Screening. Four hundred thousand plaque-forming units of a library constructed from human placental genomic DNA, partially digested with Sau3A and cloned in EMBL-3 (Clontech), were screened by hybridization with a 32P-labeled probe made from the full-length human erythrocyte band 4.2 cDNA (see below). Six positive reacting clones with an average insert size of 15 kilobases (kb) were isolated and subcloned in p-Gem4Z (Promega) with the restriction enzyme Sac I (New England Biolabs) for restriction enzyme mapping and sequencing. The full-length band 4.2 cDNA was labeled with [3 P]dCTP by primer extension using the multiprime DNA labeling system (Amersham). All other partial cDNA fragments used for Southern mapping were labeled in the same fashion.
Analysis of Genomic Subclones. Cesium chloride-banded plasmid DNA was prepared from three of the positive genomic clones-11A, 3B, and SC (see below). These were digested with restriction endonucleases, fractionated on an agarose gel, transferred to nitrocellulose, and hybridized (11) with each of four different [32PlcDNA probes (see Results). Those DNA fragments that hybridized were sequenced by the dideoxynucleotide chain-termination method (12) .
Sequence Analysis. Nucleotide sequence was analyzed by the DNASTAR (IntelliGenetics) program. Amino acid sequences were aligned and gapped by using the AALIGN program in DNASTAR.
Amplification of the 5' Region of Band 4.2 cDNA by Primer Extension. Reticulocyte RNA (13) was primed with an antisense oligonucleotide complementary to band 4.2 cDNA nucleotides +511 to +529, ¶ reverse transcribed, and subsequently 3' tailed with poly(G) using terminal deoxynucleotidyltransferase according to the method of Loh et al. (14) . Second-strand synthesis and succeeding amplifications by the polymerase chain reaction were primed with a sense tTo whom reprint requests should be addressed. §The sequence reported in this paper has been deposited in the GenBank data base (accession no. M60298).
lWe have numbered the nucleotides such that nucleotide 1 is the first A of the translation start site. This numbering differs from that used in our previous publication (6) . In addition, we have included in our nucleotide and amino acid numbering a 30-amino acid splice in exon I, which was not included in our previous work; see text.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. +2197 . Fragments of the genomic clones that hybridized with any one of the four probes were sequenced. In most cases, nonhybridizing fragments containing introns were not fully sequenced, and the approximate sizes of the introns were determined by electrophoresis following restriction endonuclease digestion. Fig. 1 shows that the human erythrocyte band 4.2 gene is "20 kb and contains 13 exons representing the total human reticulocyte cDNA. The coding sequence from the genomic DNA is identical to the cDNA sequence (6, 7). Exons I-V were contained within the genomic clone 11A and exons VI-XIII were included in genomic clone 3B. A third overlapping genomic clone, SC, was mapped with probes made from exons V and VI in order to establish the approximate size of intron 5. The exons ranged in size from 104 to 314 base pairs with an average size of 170 base pairs, while the introns varied from 6.4 to 0.3 kb. 11 Fig.  2A shows that all the exon-intron boundaries follow the consensus 5' donor-3' acceptor splice junction sequence for eukaryotic genes of gt-ag (15) . Fig. 2B shows that all three classes of intron, 0, I, and 11 (16) , are represented.
It was previously shown by Sung et al. (7) that reticulocytes contain two forms of band 4.2 mRNA, a small form encoding a protein of 691 amino acids, and a larger form, which contains an additional 90 nucleotides following nucleotide +9, encoding a protein of 721 amino acids. We have confirmed the presence of the larger band 4.2 transcript by primer extension of total reticulocyte RNA using a band 4.2-specific primer (data not shown). Further confirmation of the authenticity ofthe larger transcript was obtained from our analysis of the band 4.2 genomic sequence. Our genomic data show that band 4.2 exon I contains 5' noncoding sequence, the translation start site, and 99 nucleotides encoding 33 amino acids. These 33 amino acids are identical to the first 33 amino acids of the larger band 4.2 transcript (7) . The 3'-most 90 nucleotides of exon I, coding for 30 amino acids, must be removed by splicing to generate the smaller transcript, coding for the 691-amino acid protein (see Fig. 4 ). Our results therefore show that the smaller message is generated by splicing within exon I, and not by alternative exon usage. With the exception of the 30-amino acid insertion after amino acid 3, the sequence of the larger band 4.2 protein is identical to that of the smaller. Since purified band 4.2 migrates as a single band in SDS/polyacrylamide gels (2) one'of the'traniscripts is expected to' predominate over the other in the reticulocyte and, presumably, in the mature erythrocyte. Northern analysis of total human reticulocyte RNA using a full-length cDNA encoding the 691-amino acid band 4.2 form revealed only one band of -2.4 kb (data not shown). However, it was not possible to determine whether this band represented the smaller or larger form. To determine which form of the two band 4.2 message sizes predominated, reticulocyte'RNA was reverse transcribed with an antisense primer from the 5' coding sequence (see Methods). Electrophoresis of the PCR reaction products in an agarose gel followed by staining with ethidium bromide revealed the presence of two bands (data not shown). By visual inspection, it was clear that the product corresponding to the smaller transcript was present in much greater abundance than was that corresponding to the larger. Both products were subcloned and sequenced to verify that they represented the two transcripts in question. We conclude from this that the smaller gene product of 691 amino acids is the predominant band 4.2 protein seen on SDS/polyacrylamide gels of human erythrocyte ghosts.
The primer-extension experiment described above was also used to derive the nucleotide sequence close to the transcription start site of the band 4.2 gene (Fig. 3A) . The most 5' sequences of the two transcripts obtained were identical (verifying that they are derived from a single gene) and extended to nucleotide -214, numbering backwards from the translation start site. However, this position was 12 nucleotides downstream of the most 5' sequence generated by Sung et al. (7) , which extended to nucleotide -226. This apparent difference in the 5' origin of the band 4.2 transcript likely reflects a slight degradation of our reticulocyte RNA and in the following discussion we assume that the transcription start site is at nucleotide -226 (marked by an arrow in Fig. 3A) . Here, nucleotide 1 is the first A of the translation start; nucleotides and amino acids are numbered to include the unspliced sequence of exon I (see Fig. 4 and ref. 7) .
In Fig. 3B (22) ; (ii) a short G+C-rich domain, which could be an Spl binding site (20) ; (iii) a likely (but nonstandard) CAAT box (22) ; (iv) a CAAC box (18, 21) ; (v) two GF-1 binding domains (17) , one at -23 to -28 (shown only in Fig. 3A at positions -249 to -254; note numbering difference between Fig. 3 A and B, as discussed above) and one at -173 to -178 (Fig. 3B) (Fig.  4) . It should be noted that exon I of the a subunit of factor XIII contains only untranslated sequence, so the exon pairing starts with exon II of factor XIII. Exon I of band 4.2 contains 5' untranslated sequence (data not shown) and sequence coding for 33 amino acid residues. Of these, residues 3-33 are the ones removed by splicing to produce the major 691-amino acid transcript, as discussed above, and are indicated by a superscribed line. Examination of Fig. 4 reveals that the degree of sequence identity between the paired exons varies considerably. However, examination of the sizes of the paired exons reveals that, with only one exception, each exon of band 4.2 is very similar and in many cases identical in size to the exon of the a subunit of factor XIII with which it is paired. The one exception is that the a subunit of factor XIII has an intron between exons X and XI (intron position marked by arrow in Fig. 4) , whose combined sequence corresponds to band 4.2 exon IX. It should also be noted that while the last exon of band 4.2 (XIII) and the last exon of the a subunit offactor XIII (XV) encode a comparable number of amino acid residues, they are dissimilar in nucleotide number since each contains different numbers of noncoding residues.
We have also compared the splice junction classes (16) Proc. Natl. Acad. Sci (Fig. 2B) shuffling). The fact that the sequence identities between the two proteins are limited to half or fewer of the paired exons shown in Fig. 4 could be an argument for exon shuffling between these two genes or between these genes and another, as yet unidentified, gene. In view of the similarity in gene structure (see Results), a more likely explanation is that one of the two genes was derived from the other or that the two were derived from a common ancestor. The lineage of these proteins can be further explored by comparing the overall sequence identity of band 4.2 with two transglutaminases of human origin, the a subunit of factor XIII (23, 24) and endothelial cell transglutaminase (25) . Analysis of these sequences by the'ALP3 program (Bionet) revealed that the a subunit of factor XIII is 36% identical to endothelial cell transglutaminase but'only 25% identical to band 4.2, while endothelial cell transglutaminase is 32% identical to band 4.2. This suggests that endothelial cell transglutaminase is more similar to the a subunit of factor XIII than is band 4.2, while band 4.2 is more similar to endothelial cell transgluta'minase than to the a subunit of factor XIII. Ordering the proteins in this way suggests that band 4.2 may have evolved from endothelial cell transglutaminase, which in turn evolved from the a subunit offactor XIII. In this context, it may be of some significance that the gene for the a subunit of human factor XIII is considerably larger than that for band 4.2 (160 kb versus 20 kb for band 4.2) due mostly to the larger sizes of its introns (10) and has a somewhat larger coding sequence (732 amino acids versus 721 amino acids for'band 4.2), suggesting greater antiquity (26, 27) .
The exon pairing that results from the optimal alignment of the amino acid' sequences of the two proteins pairs exon II of the a subunit of factor XIII with exon I of band 4.2 (see Fig.  4 ). While these exons have no sequence identity, they do have several features in common. In both proteins, most of the amino acids encoded by these exons are subject to elimination, albeit by two distinct mechanisms. As noted above, the predominant form of band 4.2 is generated by alternative splicing of the nucleotides within exon I encoding 30 of 33 amino acids. The a subunit offactor XIII on the other hand is subject to posttranslational proteolysis of its first 37 amino acids encoded by exon II (28) . While the genes differ in several respects, one prominent difference relates to the pairing of band 4.2 exon IX with the a subunit of factor XIII exons X and XI, between which the a subunit of factor XIII has an intron. If the genes for band 4.2 and the a subunit of factor XIII are'closely related, then at some time in evolutionary history this intron was either deleted from the band 4.2 gene or was inserted into the gene for the a subunit of factor XIII. Examples of both types of splicing events have been reported (29) (30) (31) (32) . In the overall comparison of the gene for human erythrocyte band 4.2 with the gene for the a subunit of human factor XIII, it is evident that the coding sequences are less similar than is the organization of the genes (exon size and intron splice junction class). This suggests the possibility that there has been greater selective pressure to retain the genomic organization than to preserve sequence identity. The significance of the similarities in genomic organization and/or amino acid sequence may be clarified when further data regarding the function of erythrocyte band 4.2 and intracellular transglutaminases become available.
